Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Fish and Richardson
AstraZeneca
Harvard Business School
Accenture
Cantor Fitzgerald
Farmers Insurance
UBS

Generated: December 12, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090103

« Back to Dashboard

NDA 090103 describes NIMODIPINE, which is a drug marketed by Bionpharma Inc, Heritage Pharms Inc, Sofgen Pharms, Sun Pharm Inds Inc, and Thepharmanetwork Llc, and is included in five NDAs. It is available from ten suppliers. Additional details are available on the NIMODIPINE profile page.

The generic ingredient in NIMODIPINE is nimodipine. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nimodipine profile page.
Summary for 090103
Tradename:NIMODIPINE
Applicant:Thepharmanetwork Llc
Ingredient:nimodipine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 090103
Mechanism of ActionCalcium Channel Antagonists
Medical Subject Heading (MeSH) Categories for 090103
Suppliers and Packaging for NDA: 090103
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIMODIPINE nimodipine CAPSULE;ORAL 090103 ANDA Major Pharmaceuticals 0904-6566 0904-6566-04 30 BLISTER PACK in 1 BOX, UNIT-DOSE (0904-6566-04) > 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
NIMODIPINE nimodipine CAPSULE;ORAL 090103 ANDA Major Pharmaceuticals 0904-6566 0904-6566-61 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0904-6566-61) > 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength30MG
Approval Date:Apr 7, 2014TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Merck
Cerilliant
Fuji
Cantor Fitzgerald
Julphar
Teva
Boehringer Ingelheim
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.